Leading expert in pediatric rheumatology, Dr. Randy Cron, MD, explains how children with arthritis can lead normal lives. He discusses the shock of a juvenile arthritis diagnosis. Dr. Randy Cron, MD, highlights the effectiveness of modern medications. The goal of treatment is complete disease control and normal childhood development.
Living a Normal Life with Juvenile Arthritis: Treatment Goals and Outcomes
Jump To Section
- Juvenile Arthritis Diagnosis Shock
- Modern Arthritis Treatment Advances
- Treatment Goals for Children
- Parent Questions About Arthritis
- Hope for Families With Arthritis
- Full Transcript
Juvenile Arthritis Diagnosis Shock
Dr. Randy Cron, MD, describes the common shock families experience when a child receives a juvenile arthritis diagnosis. Most people are completely unaware that children can develop chronic arthritis. The general public typically associates arthritis with older adults. Dr. Anton Titov, MD, explores this surprising aspect of pediatric rheumatic diseases in the interview.
Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. It affects approximately 1 in 1,000 children under age 16. The peak onset occurs around age two, making it a condition that affects even the youngest children. This early onset makes the diagnosis particularly surprising for families without prior experience with childhood arthritis.
Modern Arthritis Treatment Advances
Dr. Randy Cron, MD, emphasizes the significant advances in juvenile arthritis medications. Modern therapies have become remarkably effective at controlling disease activity. These treatments include disease-modifying antirheumatic drugs (DMARDs) and biologic agents. These medications target specific inflammatory pathways that drive arthritis symptoms.
The improvement in treatment options represents a major shift in pediatric rheumatology care. Dr. Randy Cron, MD, notes that current medications achieve what wasn't possible in previous decades. This therapeutic progress has transformed outcomes for children with rheumatic diseases. The interview with Dr. Anton Titov, MD, highlights how these advances directly impact quality of life.
Treatment Goals for Children
The primary treatment goal for juvenile arthritis is enabling children to lead normal lives. Dr. Randy Cron, MD, explains that complete disease control is now an achievable objective. This means children can participate fully in school, sports, and social activities. Treatment aims to eliminate pain and prevent joint damage that could limit function.
Normal childhood development remains the central focus of arthritis management. This includes physical growth, emotional well-being, and educational progress. Dr. Randy Cron, MD, emphasizes that modern approaches address the whole child, not just the arthritis symptoms. The discussion with Dr. Anton Titov, MD, reinforces this comprehensive treatment philosophy.
Parent Questions About Arthritis
Dr. Randy Cron, MD, encourages parents to ask about long-term quality of life. The question "Can my child live a normal life?" is particularly important. This question addresses both immediate concerns and future aspirations. Many parents hesitate to ask this directly, though it's always on their minds.
Open communication about prognosis and expectations is crucial for family coping. Dr. Cron makes a point to discuss normal life outcomes even when parents don't ask. This proactive approach helps families develop realistic hope and understanding. Dr. Anton Titov, MD, facilitates this important conversation about patient-physician communication.
Hope for Families With Arthritis
Despite the challenges of a chronic condition diagnosis, Dr. Randy Cron, MD, offers substantial hope. Effective therapy is available for children with juvenile arthritis. The availability of successful treatment transforms what was once a devastating diagnosis. Families can now anticipate positive outcomes with proper medical management.
The emotional impact of a juvenile arthritis diagnosis remains significant, but the therapeutic landscape has dramatically improved. Dr. Cron's message emphasizes that while the diagnosis is serious, the prognosis is increasingly positive. This balanced perspective helps families navigate the complex journey ahead. Dr. Anton Titov, MD, helps convey this encouraging outlook to families seeking information.
Full Transcript
Dr. Anton Titov, MD: Is there a question that patients or their parents should ask, but don't ask that often?
I would like them to ask, and this is, first of all, it often comes as a shock to a family, for example, that the child may have arthritis, or lupus, or whatever rheumatic disease they have, because most people don't think of kids as having those diseases.
In general, the general public—most families, unless they've potentially had a relative who had it as a child—are completely unaware that children get chronic arthritis.
And actually, the most common age that we see is around age two, so some of the really youngest kids.
So number one is typically a shock.
Dr. Randy Cron, MD: But what I'd like them to ask, but what I usually tell them anyway, is that because, like we were talking about, the medicines have gotten so good that for the most part, our goal is for the child to lead a normal life.
We could not do that before with the medicines we had available to us.
We could try, but now we can actually do it.
And so I'd like them to ask, can my child live a normal life?
Some people do ask me that.
It's a great question.
So I wish more would ask me that because, as sad as it is to have a child diagnosed with any chronic condition, particularly something like arthritis, the good news is we have therapy that's available for them.